Generate source-backed buy-side equity research memos from a ticker, starting with investment view, target-price scenarios, SEC and IR-backed financial statement analysis, industry chain, competition, valuation, catalysts, variant perception, risks, and monitoring dashboard. Use when the user asks to analyze a stock or ticker, create a buy-side memo, investment committee note, deep equity research report, SOTP or scenario-driven stock analysis, or fund-manager-style company analysis.
Evaluate a stock's valuation using TAM-Adj-PEG, adjusting traditional PEG by growth runway and quality. Use when the user provides a ticker or asks whether a growth stock's valuation is cheap, expensive, TAM-supported, runway-supported, quality-adjusted, or suitable as core growth, high-beta growth, turnaround, option-like, or cyclical exposure.
Use a Bayesian intrinsic-growth valuation model to evaluate whether a company's market value sufficiently, excessively, or insufficiently prices its real 3-5 year growth. Use when the user asks for Bayesian valuation, intrinsic growth rate, implied growth, growth-hypothesis probabilities, FOMO versus fundamentals, or company analysis based on fundamentals, industry cycle, TAM, market share, margin, valuation multiples, and new information.
Score a stock's current valuation/trend health using the GF-DMA Health Index, combining fundamental growth speed, 20/50/100/200DMA trend speed, price-to-DMA divergence, ATR divergence, escape ratio, and estimate revisions. Use when the user provides a ticker or asks for GF-DMA scoring, valuation health, trend health, healthy momentum, overheated/escape risk, or whether a rising/falling stock is fundamentally supported.
Translate market-moving news into investable alpha hypotheses by mapping observed demand changes to revenue lines, supply chains, small-cap financial elasticity, market misclassification, validation metrics, downside risks, and position-sizing conditions. Use when the user shares news, product launches, technology breakthroughs, procurement signals, supply-chain changes, earnings-call clues, or asks for Serenity-style alpha analysis, small-cap beneficiaries, or "news to financial statement" translation.